Arrhythmia

Latest News

Reducing the Risk of Device-Related Thrombosis Following LAA Closure

Future research needs to look at the role of antithrombotic therapy following percutaneous left atrial appendage closure.

Apixaban Superior to Warfarin in Chronic Kidney Disease With Atrial Fibrillation

Patients with CKD stage 3 or 4 and atrial fibrillation treated with apixaban vs warfarin have a 36% decreased risk of stroke or venous thromboembolism, a meta-analysis found.

Attorney Ads May Influence DOAC Users to Discontinue Meds Without Medical Advice

According to the findings of a recent study, attorney advertisements appear to influence patients’ decisions on modifying or discontinuing their direct oral anticoagulant (DOAC) medication prior to seeking medical advice.

Preablation Bariatric Surgery Linked to Reduced Atrial Fibrillation Recurrence

For morbidly obese patients with atrial fibrillation (AF), those undergoing preablation bariatric surgery have reduced rates of recurrence.

Less Bleeding Risk With Apixaban Without Aspirin After ACS in Atrial Fibrillation

In patients with atrial fibrillation and a recent acute coronary syndrome or PCI treated with a P2Y12 inhibitor, an antithrombotic regimen that included apixaban, without aspirin, resulted in less bleeding and fewer hospitalizations.

Wait-and-See Method Noninferior to Early Cardioversion for Early-Onset Afib

Among patients who presented to the emergency department with recent-onset symptomatic atrial fibrillation, a wait-and-see strategy was noninferior to early cardioversion in obtaining sinus rhythm at 4 weeks after the index visit.

FDA Clears Personal ECG Device for Bradycardia, Tachycardia Detection

The FDA has cleared KardiaMobile (AliveCor), a personal ECG device, for use in detecting bradycardia and tachycardia.

AI Able to Identify Cardiac Rhythm Devices From Radiographs

A neural network can accurately identify the manufacturer and model group of a cardiac rhythm device from a chest radiograph.

Factors Associated With Bleeding Events in Anticoagulated Patients With Afib

Attending to modifiable risk factors is an important treatment target in patients with atrial fibrillation treated with anticoagulants to reduce thromboembolic and bleeding events.

Female Sex Independently Associated With Worse Catheter Ablation Outcomes in Afib

Women have higher rates of complications and hospital readmission following atrial fibrillation ablation independent of age, comorbidities, and hospital factors.